AHSG and breast carcinoma: Using 2D immunoblot analysis to screen sera from patients with a diagnosis of breast cancer for auto-antibodies reactive to human fetuin-A, Fernandez-Grijalva et al. [62] reported that serum autoantibodies against AHSG could be useful as serum biomarkers for early-stage breast cancer.